Literature DB >> 6962179

Morphological changes, cell aggregation and cell membrane alterations caused by phorbol 12,13-dibutyrate in human blood lymphocytes.

M Patarroyo, G Yogeeswaran, P Biberfeld, E Klein, G Klein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6962179     DOI: 10.1002/ijc.2910300606

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

1.  The Epstein-Barr virus BNLF-1 membrane protein LMP1 induces homotypic adhesion mediated by CD11a/CD18 in a murine B-cell line, mimicking the action of phorbol ester.

Authors:  R Salcedo; S M Fuerstenberg; M Patarroyo; G Winberg
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1.

Authors:  C Cabañas; N Hogg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

3.  Cyclosporin A inhibits mitogen-activated but not phorbol ester-activated locomotion of human lymphocytes.

Authors:  P C Wilkinson; A Higgins
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

4.  Myristoylated alanine-rich C-kinase substrate (MARCKS) protein regulation of human neutrophil migration.

Authors:  Rachael E Eckert; Laura E Neuder; Joungjoa Park; Kenneth B Adler; Samuel L Jones
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-02       Impact factor: 6.914

5.  Effect of a phorbol ester on basic surface properties of trichomonads.

Authors:  V L Bonilha; E M Saraiva; F C Silva Filho
Journal:  Cell Biophys       Date:  1992-02

6.  Loss of intercalated membrane particles by treatment with phorbols.

Authors:  D Zucker-Franklin; Z F Nabi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester.

Authors:  R Rothlein; T A Springer
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.